TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis

Journal of Acquired Immune Deficiency Syndromes

Volumn 64, Issue 2, 2013, Pages 204-210

  Guo, Yu ^a,b   Siewe, Basile ^c   Epeldegui, Marta ^a   Detels, Roger ^a,d   Landay, Alan L ^c   Martínez Maza, Otoniel ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Activation induced cytidine deaminase; AIDS lymphoma; HIV; Non Hodgkin lymphoma; Phenotype; Toll like receptor

Indexed keywords

TOLL LIKE RECEPTOR 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BURKITT LYMPHOMA; CELL ISOLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FLOW CYTOMETRY; GERMINAL CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CYTIDINE DEAMINASE; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PHENOTYPE; TOLL-LIKE RECEPTOR 2;

EID: 84885314839     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31829d4d50     Document Type: Article

References (42)

1. Huang J, et al. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. J Acquir Immune Defic Syndr. 1999;21(suppl 1):S31-S33.
2. Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med. 1984;311: 565-570.
3. Carbone A, Gloghini A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol. 2005;130: 662-670.
4. Hessol NA, Seaberg EC, Preston-Martin S, et al. Cancer risk among participants in the women's interagency HIV study. J Acquir Immune Defic Syndr. 2004;36: 978-985.
5. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008; 123: 187-194.
6. Seaberg EC, Wiley D, Martinez-Maza O, et al. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer. 2010;116: 5507-5516.
7. Gaidano G, Capello D, Carbone A. The molecular basis of acquired immunodeficiency syndrome-related lymphomagenesis. Semin Oncol. 2000;27: 431-441.
8. Epeldegui M, Vendrame E, Martinez-Maza O. HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma. Immunol Res. 2010;48: 72-83.
9. Epeldegui M, Widney DP, Martinez-Maza O. Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-associated molecular lesions. Curr Opin Oncol. 2006;18: 444-448.
10. Martinez-Maza O, Breen EC. B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol. 2002;14: 528-532.
11. Epeldegui M, Thapa DR, De la Cruz J, et al. CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes. PLoS One. 2010;5:e11448.
12. Martin G, Roy J, Barat C, et al. Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells. J Virol. 2007;81: 5872-5881.
13. Imbeault M, Ouellet M, Giguere K, et al. Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. J Virol. 2011;85: 2189-2200.
14. Breen EC, Hussain SK, Magpantay L, et al. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Cancer Epidemiol Biomarkers Prev. 2011;20: 1303-1314.
15. Siewe BKA, Kazmi N, Losurdo J, et al. Toll-like receptor (TLR)-mediated activation of peripheral and gut associated lymphoid tissue (GALT) B cells in HIV infection. Presented at: Conference on Retroviruses and Opportunistic Infections (CROI); March 4-10, 2012; Seattle, WA.
16. Martinez-Maza O, Crabb E, Mitsuyasu RT, et al. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol. 1987;138: 3720-3724.
17. Honjo T, Kinoshita K, Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol. 2002;20: 165-196.
18. Okazaki IM, Hiai H, Kakazu N, et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med. 2003;197: 1173-1181.
19. Pasqualucci L, Bhagat G, Jankovic M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet. 2008;40: 108-112.
20. Epeldegui M, Breen EC, Hung YP, et al. Elevated expression of activation induced cytidine deaminase in peripheral blood mononuclear cells precedes AIDS-NHL diagnosis. AIDS. 2007;21: 2265-2270.
21. Regidor DL, Detels R, Breen EC, et al. Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS. 2011;25: 303-314.
22. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000; 403: 503-511.
23. Freedman AS, Nadler LM. Immunologic markers in non-Hodgkin's lymphoma. Hematol Oncol Clin North Am. 1991;5: 871-889.
24. Detels R, Jacobson L, Margolick J, et al. The multicenter AIDS Cohort Study, 1983 to.. Public Health. 2012;126: 196-198.
25. Epeldegui M, Hung YP, McQuay A, et al. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutationinducing molecules and in the accrual of oncogene mutations. Mol Immunol. 2007;44: 934-942.
26. Van Baarle D, Wolthers KC, Hovenkamp E, et al. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J Infect Dis. 2002;186: 405-409.
27. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol. 2009;9: 235-245.
28. Damle RN, Ghiotto F, Valetto A, et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigenexperienced B lymphocytes. Blood. 2002;99: 4087-4093.
29. Dogan A, Bagdi E, Munson P, et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol. 2000;24: 846-852.
30. Munro JM, Freedman AS, Aster JC, et al. In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and the malignant cells of Hodgkin's disease. Blood. 1994;83: 793-798.
31. Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood. 2001;98: 3406-3412.
32. Mocroft A, Katlama C, Johnson AM, et al. AIDS across Europe, 1994- 98: the EuroSIDA study. Lancet. 2000;356: 291-296.
33. Mandl JN, Barry AP, Vanderford TH, et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med. 2008;14: 1077-1087.
34. Baenziger S, Heikenwalder M, Johansen P, et al. Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood. 2009;113: 377-388.
35. Siewe B, Keshavarzian A, French A, Demarais P, Landay A. A role for TLR signaling during B-cell activation in antiretroviral (ART) treated HIV individuals. AIDS Res Hum Retroviruses. 2013 Jun 13. [Epub ahead of print] PMCID: 23763346
36. Smith TJ, Yamamoto K, Kurata M, et al. Differential expression of Tolllike receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma. Exp Mol Pathol. 2010;89: 284-290.
37. Muzio M, Bertilaccio MT, Simonetti G, et al. The role of toll-like receptors in chronic B-cell malignancies. Leuk Lymphoma. 2009;50: 1573-1580.
38. Muzio M, Scielzo C, Bertilaccio MT, et al. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells. Br J Haematol. 2009;144: 507-516.
39. LeBien TW, McCormack RT. The common acute lymphoblastic leukemia antigen (CD10) - emancipation from a functional enigma. Blood. 1989;73: 625-635.
40. Weinberg OK, Ma L, Seo K, et al. Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin. Am J Surg Pathol. 2009;33: 591-598.
41. Abdi J, Engels F, Garssen J, et al. The role of toll-like receptor mediated signalling in the pathogenesis of multiple myeloma. Crit Rev Oncol Hematol. 2011;80: 225-240.
42. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12: 1365-1371.